ALC(ALC)
ALC
ANALYST COVERAGE25 analysts
HOLD
▲ +18.2%upside to target
L $70.00
Med $78.00consensus
H $97.00PRICE
Prev Close
63.64
Open
64.93
Day Range64.52 – 66.10
64.52
66.10
52W Range61.84 – 92.55
61.84
92.55
13% of range
VOLUME & SIZE
Avg Volume
1.8M
FUNDAMENTALS
P/E Ratio
39.5x
EPS (TTM)
—
Div Yield
0.00%
Beta
0.87
Market-like
TECHNICAL
RSI (14)
27
Oversold
Upcoming Events
EEarnings Report
Tomorrow
May 20
DEx-Dividend
In 90 days
Aug 17
PDividend Pay
In 119 days
Sep 15
Key MetricsTTM
Market Cap$32.15B
Revenue TTM$10.58B
Net Income TTM$815.33M
Free Cash Flow$1.70B
Gross Margin54.9%
Operating Margin12.3%
Net Margin7.7%
Return on Equity3.7%
Return on Assets2.6%
Debt / Equity0.24
Current Ratio2.20
EPS TTM$1.67
ALC News
About
Alcon is an American Swiss medical company specializing in eye care products with headquarters in Geneva, Switzerland, and incorporated in Fribourg, Switzerland.
Laurent AttiasSenior VP of Corporate Strategy, Business Development and Licensing (BD&L), M&A
Leon Sergio Duplan FraustroSenior Vice President & President of Americas
Timothy C. StonesiferSenior Vice President & Chief Financial Officer
Kimberly MartinSenior VP and Chief HR & Corporate Communications
Royce R. BedwardSenior Vice President, General Counsel & Corporate Secretary
Ian BellSenior Vice President & Chief Operating Officer
Muru MurugappanSenior Vice President and Chief Information & Transformation Officer
Franck LeveillerSVP of Global Research & Development and Chief Scientific Officer
Margaret BuckleyChief Accounting Officer
David J. EndicottChief Executive Officer & Director